200 related articles for article (PubMed ID: 16207822)
1. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia.
Xu Y; Hashizume T; Shuhart MC; Davis CL; Nelson WL; Sakaki T; Kalhorn TF; Watkins PB; Schuetz EG; Thummel KE
Mol Pharmacol; 2006 Jan; 69(1):56-65. PubMed ID: 16207822
[TBL] [Abstract][Full Text] [Related]
2. Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs.
Yasuda K; Ikushiro S; Kamakura M; Takano M; Saito N; Kittaka A; Chen TC; Ohta M; Sakaki T
J Steroid Biochem Mol Biol; 2013 Jan; 133():84-92. PubMed ID: 22982757
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 is a human microsomal vitamin D 25-hydroxylase.
Gupta RP; Hollis BW; Patel SB; Patrick KS; Bell NH
J Bone Miner Res; 2004 Apr; 19(4):680-8. PubMed ID: 15005856
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis.
Gupta RP; He YA; Patrick KS; Halpert JR; Bell NH
J Clin Endocrinol Metab; 2005 Feb; 90(2):1210-9. PubMed ID: 15546903
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia.
Wang Z; Lin YS; Dickmann LJ; Poulton EJ; Eaton DL; Lampe JW; Shen DD; Davis CL; Shuhart MC; Thummel KE
J Bone Miner Res; 2013 May; 28(5):1101-16. PubMed ID: 23212742
[TBL] [Abstract][Full Text] [Related]
7. Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1.
Sawada N; Kusudo T; Sakaki T; Hatakeyama S; Hanada M; Abe D; Kamao M; Okano T; Ohta M; Inouye K
Biochemistry; 2004 Apr; 43(15):4530-7. PubMed ID: 15078099
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression.
Gibbs MA; Thummel KE; Shen DD; Kunze KL
Drug Metab Dispos; 1999 Feb; 27(2):180-7. PubMed ID: 9929500
[TBL] [Abstract][Full Text] [Related]
9. Abiraterone inhibits 1α,25-dihydroxyvitamin D3 metabolism by CYP3A4 in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():50-8. PubMed ID: 24269662
[TBL] [Abstract][Full Text] [Related]
10. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Lown KS; Watkins PB
Mol Pharmacol; 1997 May; 51(5):741-54. PubMed ID: 9145912
[TBL] [Abstract][Full Text] [Related]
11. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.
Wang Z; Lin YS; Zheng XE; Senn T; Hashizume T; Scian M; Dickmann LJ; Nelson SD; Baillie TA; Hebert MF; Blough D; Davis CL; Thummel KE
Mol Pharmacol; 2012 Apr; 81(4):498-509. PubMed ID: 22205755
[TBL] [Abstract][Full Text] [Related]
12. Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D₃ function in human colon adenocarcinoma LS180 cells.
Zheng XE; Wang Z; Liao MZ; Lin YS; Shuhart MC; Schuetz EG; Thummel KE
Biochem Pharmacol; 2012 Aug; 84(3):391-401. PubMed ID: 22562045
[TBL] [Abstract][Full Text] [Related]
13. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Watkins PB
Drug Metab Dispos; 2001 Nov; 29(11):1446-53. PubMed ID: 11602520
[TBL] [Abstract][Full Text] [Related]
14. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
[TBL] [Abstract][Full Text] [Related]
15. The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism.
Uga M; Kaneko I; Shiozaki Y; Koike M; Tsugawa N; Jurutka PW; Miyamoto KI; Segawa H
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927120
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of 1,25-dihydroxyvitamin D3 and EB 1089 on mouse renal and intestinal 25-hydroxyvitamin D3-24-hydroxylase.
Roy S; Martel J; Tenenhouse HS
J Bone Miner Res; 1995 Dec; 10(12):1951-9. PubMed ID: 8619376
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 3A-mediated microsomal biotransformation of 1α,25-dihydroxyvitamin D3 in mouse and human liver: drug-related induction and inhibition of catabolism.
Deb S; Pandey M; Adomat H; Guns ES
Drug Metab Dispos; 2012 May; 40(5):907-18. PubMed ID: 22301272
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
19. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
[TBL] [Abstract][Full Text] [Related]
20. Hydroxylation of 20-hydroxyvitamin D3 by human CYP3A4.
Cheng CY; Slominski AT; Tuckey RC
J Steroid Biochem Mol Biol; 2016 May; 159():131-41. PubMed ID: 26970587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
